SCHEMBL6733188

SCHEMBL6733188

O=C(O)[C@H]1CCCC[C@@H]1c1ccc(CN(C(=O)N2CCCC2)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
AGTR2 P50052 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRM2 P08172 3/20 0.39
CHRM1 P11229 3/20 0.39
CHRM3 P20309 3/20 0.39
ATM Q13315 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
OPRD1 P41143 2/20 0.38
KCNQ3 O43525 2/20 0.37
KCNQ2 O43526 2/20 0.37
PTPRB P23467 1/20 0.37
PTPN11 Q06124 1/20 0.37
STAT3 P40763 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6737836 0.92 PREP (0.39) ALDH1A1AGTR2CHRM2CHRM1CHRM3
SCHEMBL5718155 0.92 ALDH1A1 (0.42) ALDH1A1AGTR2CHRM2CHRM1CHRM3
SCHEMBL6733285 0.82 KCNQ3 (0.63) ATMSLC6A2SLC6A4KCNQ3KCNQ2
SCHEMBL5838740 0.79 PTPRB (0.42) ALDH1A1SMN1; SMN2CHRM2CHRM1CHRM3
SCHEMBL6737598 0.79 SLC6A2 (0.45) ATMSLC6A2SLC6A4KCNQ3KCNQ2
SCHEMBL20236474 0.77 LTB4R2 (0.50) ALDH1A1POLBSMN1; SMN2LTB4R2
SCHEMBL28363637 0.76 ALDH1A1 (0.49) ALDH1A1POLBSMN1; SMN2
SCHEMBL20236747 0.76 LTB4R2 (0.49) ALDH1A1POLBSMN1; SMN2LTB4R2
SCHEMBL5718068 0.76 ATM (0.40) ALDH1A1ATMLTB4R2SLC6A2SLC6A4
SCHEMBL5717911 0.76 KCNQ3 (0.44) ALDH1A1KCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235830-A1 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases BAYER AKTIENGESELLSCHAFT (DE) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235830-A1 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases CYP46A1, REN, CYP11B2 ALDH1A1 348/4885AGTR2 100/4885POLB 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.